The pathogenesis of the myopathy occurring in the heart of the cardiomyopathic strain of the Syrian hamster is not well understood but is believed to be associated with abnormal calcium handling by myopathic cells. The purpose of this study was to determine whether the cardiomyopathy occurring in strain BIO 14.6 animals is associated with an enhanced a1-adrenergic receptor-mediated rise in cytosolic calcium, whether a pertussis toxin-sensitive G protein is involved in coupling the al-adrenergic receptor to changes in intracellular calcium and whether enhanced al responsiveness is associated with an increase in the level of expression of the a1-adrenergic receptor or in the pertussis toxin-sensitive G protein or proteins. To test the hypothesis that the cardiomyopathic state is associated with a greater ael-receptor-mediated rise in cytosolic calcium, we studied the effect of phenylephrine (in the presence of propranolol) on time-averaged cytosolic calcium concentration ([Ca2+] ) in isolated cardiac myocytes from cardiomyopathic and age-matched control hamsters. Phenylephrine caused a greater increase both in time-averaged [Ca2"ji (an increase of 48±8% versus 12 ±3%, p <0.01) and in contractility (+ 181±22% versus +35+9%, p <0.01) in cardiomyopathic than in normal cardiac myocytes. Exposure to pertussis toxin (200 ng/ml for 3 hours) attenuated the cc1-adrenergic receptor-mediated increase in contractility and time-averaged [Ca2+]i in both cardiomyopathic and normal cells. The level of pertussis toxin-sensitive G protein, as determined by pertussis toxin-mediated [32P]A)DP-ribosylation, was 1.6-fold higher in cardiomyopathic versus normal hamster hearts. The density of a1-adrenergic receptors, as measured by the antagonist radioligand [3Hlprazosin and the affinity of the receptor for agonist and antagonist were similar in myopathic and normal heart membranes. Thus, in cardiac myocytes from hamsters, the al-adrenergic receptor-mediated effects on [Ca2`]i and contractility appear to be mediated by a pertussis toxin-sensitive G protein or proteins. In myocytes from cardiomyopathic hamsters, these al-adrenergic effects were increased in magnitude, as was the level of pertussis toxin-sensitive G protein, but there was no measurable alteration in the density or ligand binding properties of al-adrenergic receptors. (Circulation Research 1990;67:1182-1192 T he cardiomyopathic Syrian hamster is known to develop a genetically determined cardiomyopathy associated with progressive development of congestive heart failure.1 This model has been used for studies of fundamental cellular abnormalities in heart failure.2 However, the primary de-
The pathogenesis of the myopathy occurring in the heart of the cardiomyopathic strain of the Syrian hamster is not well understood but is believed to be associated with abnormal calcium handling by myopathic cells. The purpose of this study was to determine whether the cardiomyopathy occurring in strain BIO 14.6 animals is associated with an enhanced a1-adrenergic receptor-mediated rise in cytosolic calcium, whether a pertussis toxin-sensitive G protein is involved in coupling the al-adrenergic receptor to changes in intracellular calcium and whether enhanced al responsiveness is associated with an increase in the level of expression of the a1-adrenergic receptor or in the pertussis toxin-sensitive G T he cardiomyopathic Syrian hamster is known to develop a genetically determined cardiomyopathy associated with progressive development of congestive heart failure.1 This model has been used for studies of fundamental cellular abnormalities in heart failure.2 However, the primary de-hanced positive inotropic response to a1-adrenoceptor stimulation. 5 Myopathic animals, at all stages of the disease including the prenecrotic phase, also exhibit increased intracardiac turnover of norepinephrine6 and the enzymes of the catecholamine biosynthetic pathway. 7 The density of radioligand binding sites for a-and ,B-adrenergic receptors has been reported to be increased8,9 in the dystrophic myocardium. Finally, chronic administration of the a1-adrenergic antagonist prazosin has been reported to prevent the development of cardiomyopathy. 3 Stimulation of the myocardial a1-adrenergic receptor leads to an increase in the slow inward Ca2' current and a rise in cytosolic Ca2' concentration ([Ca2+]`).10 Therefore, a1-adrenergic receptor stimulation could contribute to Ca2' overload, which, in turn, might lead to cardiac myocyte damage. 15 . After 8 minutes of perfusion to clear blood from the heart, the same buffer solution was used except that the perfusate was changed to nominally zero calcium. The heart ceased contraction after change to this medium. Then, 0.03% collagenase and 0.015% hyaluronidase were added to this calciumfree medium and recirculated through the heart. Perfusion was continued for 30 minutes, during which time the heart became swollen and pale. The ventricles were removed, cut into small pieces (2 mm3), and placed in a flask containing 0.03% collagenase, 0.015% hyaluronidase, 0.001% trypsin, and 1.0 mM CaCl2 in Krebs-Henseleit physiological solution. The tissue fragments were shaken in an orbital shaking (120 cycles/min) water bath at 370 C for 15 minutes. Tissue pieces were then placed in a calciumfree buffer containing 0.05% collagenase and 0.03% hyaluronidase. The tissue pieces were pipetted up and down 10 times with a 5-ml plastic pipette, the tip of which was cut back so that the diameter of the orifice was approximately 6 mm. Warm (370 C) oxygenated calcium-free buffer was added to the tube, and the cells were centrifuged at 400 rpm for 1 minute. The cells were then washed twice using the same method. Disaggregation of a single heart produced approximately 5 x 106 cells from a cardiomyopathic or healthy hamster. The cells were then suspended in physiological buffer of the desired calcium concentration. At this point, 90-95% of cardiomyopathic cells and greater than 95% of normal cells were rod shaped. After 5 minutes in this buffer, an additional 5% of cells from either preparation became rounded. The percentages of rod-shaped cells remained stable for the subsequent 4 hours.
Measurement of Contractility
For contractility measurements, single adult cardiomyocytes were attached to glass coverslips with collagen (Vitrogen 400, Palo Alto, Calif.) and placed in a specially designed chamber that permitted continuous flow of superfusing medium. The chamber was placed on the stage of an inverted phase-contrast microscope (Diavert, Leitz, Wetzlar, FRG) enclosed in a Lucite box with controlled temperature (370 C).
The cells were electrically stimulated at a frequency of 1.5 Hz using a platinum electrode. The pulse was square wave, 4 msec in duration, and 30% above threshold voltage (typically 5 V). Light-dark contrast at the edge of the cell provided a marker for measurement of the amplitude of motion along the axis of shortening. Movement For comparison of levels of PT-catalyzed [32P]ADP-ribosylation in homogenates ofcardiomyopathic and healthy control hearts, homogenates of both types of hearts were incubated in the presence of the same concentrations of PT and [32P]NAD+ before electrophoresis and autoradiography. The peaks corresponding to the 40-kDa band obtained by densitometric scanning were cut out and weighed. The weight of the peak from a cardiomyopathic heart was normalized to that of the peak from a control heart.
[3HjPrazosin Binding
[3H]Prazosin binding was performed on a particulate fraction of myocardium. Briefly, after the animal was anesthetized with ether, the heart was rapidly excised, placed in ice-cold phosphate buffered saline and rinsed free of blood. The atria and great vessels were discarded, and the ventricular tissue was coarsely minced with scissors and homogenized in 0.25 M sucrose in a polytron (Brinkmann Instruments, Inc., Westbury, N.Y.). The homogenate was centrifuged at 1,500g for 10 minutes at 40 C, and the pellet was discarded. The supernatant was centrifuged at 48,000g for 20 minutes at 40 C, and the pellet was resuspended in assay buffer consisting of (mM) Tris HCI 50 and MgCl2 10, pH 7.50, at 200 C. The binding assay was then performed, as previously described,15 in a total volume of 1.0 ml containing [3H]prazosin (0.05-1.0 nM), the particulate fraction (approximately 1 mg/ml), and other agonists or antagonists, as indicated. Incubations (30 minutes at 300 C) were terminated by adding 4.5 ml assay buffer (room temperature) and immediately filtering the mixture through a GF/C glass fiber filter (Whatman Inc., Clifton, N.J.) followed by two more washes with assay buffer (4.5 ml each). Specific binding was defined as the counts displaced by 10 gM phentolamine and was equivalent to specific binding as defined by 1 (10 ,uM) in the presence of 1 ,uM propranolol caused an increase in contractile amplitude in both cardiomyopathic and agematched normal cardiac myocytes (Figure 1 ).
Propranolol at 1 piM completely inhibited the contractile response to 100 nM isoproterenol, which in the absence of propranolol produced a 70% increase in the amplitude of cell motion, indicating that the observed effect of phenylephrine in the presence of propranolol was mediated via an a-adrenergic receptor. Prazosin (1 ,uM) fully antagonized the 10 RM phenylephrineinduced positive inotropic response, further indicating that the effect of phenylephrine was mediated by a-adrenergic receptors of the a1 subtype ( Figure 2) . In cardiomyopathic cells, the extent of the a1-adrenergic receptor-mediated increase in contractility (+180+ 22%, n=15) was substantially greater than that observed in normal cells (35 +9%, n=15, p<0 .01 versus cardiomyopathic cells) (Figure 2 Figure 6, top panel) . The relative levels of PT-sensitive G protein in both normal and cardiomyopathic hearts were quantified by scanning the 40-kDa band with a laser densitometer ( Figure 6 , middle panel). The peaks corresponding to the 40-kDa bands were cut out and weighed, demonstrating a 1.6-fold increase (+63±12%, n=5,p<0.01) in the level of PT-sensitive G protein in hearts of cardiomyopathic hamsters compared that of normal hearts.
a1-Adrenegic Receptor Density and Affinity
To determine whether the enhanced a-adrenergic responsiveness in cardiomyopathic hearts was associated with an increase in a,-adrenergic receptor density or altered agonist binding affinity, a1-adrenoceptor stimulation is associated with an increased level of a 40-kDa PT-sensitive G protein.
Pathologically, the cardiomyopathic hamster heart is characterized by myocytolytic or contraction band necrosis, myocyte hypertrophy, and fibrosis, characteristics similar to those of catecholamine-induced myocardial damage.18"19 Prior studies reported an increased sensitivity of the microvasculature of the cremaster muscles of cardiomyopathic hamsters to topically applied norepinephrine in vivo20 and an enhanced cardiac positive inotropic response to a1-adrenoceptor stimulation.7 Furthermore, the development of features of cardiomyopathy can be prevented by administration of the a1-adrenergic antagonist prazosin to prenecrotic juvenile hamsters.3 These observations have led to the hypothesis that enhanced a,-adrenergic sensitivity may be related etiologically to the genesis of the myocardial lesions observed in the later stages of this genetically determined syndrome.3 '7 Our results with the calcium-sensitive dye fura 2 indicate that the extent of the a1-adrenergically mediated increase in [Ca2+]i in cardiac myocytes of cardiomyopathic hamsters was fourfold greater than that in normal myocytes. However, a cause-and-effect relation between cellular calcium overload and the enhanced a,-adrenergic receptor-mediated increase in [Ca2"]i cannot be established from these data. It is of interest that a1-adrenergic stimulation has been reported to cause an increase in the slow inward calcium current,10 establishing another possible link between enhanced a1-adrenergic sensitivity and excess cellular calcium. These data also provide a plausible mechanistic explanation for the beneficial effect of the a1-adrenergic antagonist prazosin in this experimental model. 3 In both myopathic and normal myocytes, the in- decrease in contractile element sensitivity to Ca21 could also play a part.
In this study, the density of a,-adrenergic receptors, as assessed by [ The role of a G protein in the coupling of myocardial a1-adrenergic receptors has been suggested by the observation that guanine nucleotides can alter agonist binding affinity, causing a shift from high to low affinity.15,26 However, this effect appears to be small in magnitude when compared with Gs-coupled receptors and has not been found consistently in all studies. 27 In the present experiments with hamster myocardium, agonist binding curves are already steep and shifted to the right and model best to a single low-affinity site, reminiscent of the effect of guanine nucleotides. Because we were unable to find any difference between myopathic and nonmyopathic hearts, this indicates that under the specific conditions of this experiment we cannot demonstrate an altered effect of guanine nucleotide on agonist binding. It is conceivable that extensive washing of the tissues might expose a high-affinity agonist binding site. However, the lack of an evident shift in agonist binding affinity in the present study ( Figure 7 ) may reflect a relatively high level of endogenous guanine nucleotide binding.
Next, we examined the possibility that the enhanced responsiveness mediated by the G protein- ADP-ribosylation in both normal and myopathic heart membranes, did not change the percent increase in the level of the G protein in the cardiomyopathic heart (data not shown). However, PT labeling only provides information on the G protein available for ADP-ribosylation, and the level of G protein labeled is probably only a small fraction of the total amount of G protein. 30 The present data must be interpreted with caution in this context. The toxin labeling of G protein may also represent primarily a functional property of the G protein. Finally, because multiple isoforms of PT-sensitive G protein are present in the heart (e.g., Gac2, Gai3, Ga0, and possibly others), it is possible that the increase in the level of [32P]ADP-ribosylation in the 40-kDa band region represents the appearance of a new Ga species or a selective increase in a particular Ga isoform.
Because PT-sensitive G protein is also coupled to muscarinic cholinergic and A, adenosine receptors in the heart,31-33 the level of PT-catalyzed [32P]ADPribosylation in membrane homogenates would be expected to represent G proteins coupled not only to a,-adrenergic receptors but also to muscarinic and A, adenosine receptors. Thus, the 1.6-fold increase in the level of PT-sensitive G protein in the cardiomyopathic hamster heart cannot be assumed to represent exclusively an increase in the PT-sensitive G protein coupled to the a,-adrenergic receptor. Conversely, the increase in G protein that is coupled to the a,-adrenergic receptor may be higher than 1.6-fold. Thus, our findings indicate that the increase in a1-adrenergic receptor-mediated functional responsiveness in cardiomyopathic cells is associated, perhaps causally, with an increase in the level of G protein through which the a,-adrenergic physiological response is coupled. Our data are of interest in relation to those of Feldman et al,7 who reported an increased level of a 40-kDa PT-sensitive G protein in failing human myocardium compared with normal controls, indicating that an increased level of PTsensitive G protein may be common to both genetically determined and acquired forms of heart failure. The present study demonstrates enhanced a,-adren-Sen et al ael-Adrenergic Receptors and G Protein in Cardiomyopathic Myocytes 1191 ergic responsiveness and increased expression of ca1-adrenergic receptor-coupled G protein in cardiomyopathic hearts and is also consistent with the view that a1-adrenergic receptors from failing human hearts are coupled to a GTP-binding protein. 34 The mechanism responsible for increased PTsensitive G protein levels in cardiomyopathic hamster hearts is not clear. Myocardial norepinephrine levels are increased in the prenecrotic stage of this process, presumably because of some abnormality of neural control or catecholamine metabolism. 3 The demonstrated relation between cardiac innervation and expression of Gi in the neonatal rat heart35 supports the possibility that the observed increase in PT-sensitive G protein is in some way related to altered sympathetic tone. We conclude that a1-adrenergic stimulation causes a greater contractile and cytosolic calcium response in isolated cardiac myocytes from cardiomyopathic hamsters than in age-matched normal cells. PT-sensitive G protein is involved in the a,-adrenergic response in both cardiomyopathic and normal cells, and enhanced a, responsiveness in cardiomyopathic myocytes is associated with an increase in PT-sensitive G protein levels, but there is no significant difference in a1-adrenergic receptor number or agonist affinity. The possibility that increased PT-sensitive G protein levels may be involved in the calcium overload that occurs in the cardiomyopathic hamster heart and may play a part in the etiology of myocardial failure deserves further study.
